BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

687 related articles for article (PubMed ID: 23376433)

  • 1. The cancer secretome, current status and opportunities in the lung, breast and colorectal cancer context.
    Schaaij-Visser TB; de Wit M; Lam SW; Jiménez CR
    Biochim Biophys Acta; 2013 Nov; 1834(11):2242-58. PubMed ID: 23376433
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sieving through the cancer secretome.
    Lin Q; Tan HT; Lim HS; Chung MC
    Biochim Biophys Acta; 2013 Nov; 1834(11):2360-71. PubMed ID: 23376431
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A high-quality secretome of A549 cells aided the discovery of C4b-binding protein as a novel serum biomarker for non-small cell lung cancer.
    Luo X; Liu Y; Wang R; Hu H; Zeng R; Chen H
    J Proteomics; 2011 Apr; 74(4):528-38. PubMed ID: 21262398
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Colon tumour secretopeptidome: insights into endogenous proteolytic cleavage events in the colon tumour microenvironment.
    Greening DW; Kapp EA; Ji H; Speed TP; Simpson RJ
    Biochim Biophys Acta; 2013 Nov; 1834(11):2396-407. PubMed ID: 23684732
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Detection of cadherin-17 in human colon cancer LIM1215 cell secretome and tumour xenograft-derived interstitial fluid and plasma.
    Bernhard OK; Greening DW; Barnes TW; Ji H; Simpson RJ
    Biochim Biophys Acta; 2013 Nov; 1834(11):2372-9. PubMed ID: 23557862
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Secretome analysis using a hollow fiber culture system for cancer biomarker discovery.
    Chiu KH; Chang YH; Liao PC
    Biochim Biophys Acta; 2013 Nov; 1834(11):2285-92. PubMed ID: 23376430
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Stem cells: insights into the secretome.
    Makridakis M; Roubelakis MG; Vlahou A
    Biochim Biophys Acta; 2013 Nov; 1834(11):2380-4. PubMed ID: 23376432
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of differentially secreted biomarkers using LC-MS/MS in isogenic cell lines representing a progression of breast cancer.
    Mbeunkui F; Metge BJ; Shevde LA; Pannell LK
    J Proteome Res; 2007 Aug; 6(8):2993-3002. PubMed ID: 17608509
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Increased WD-repeat containing protein 1 in interstitial fluid from ovarian carcinomas shown by comparative proteomic analysis of malignant and healthy gynecological tissue.
    Haslene-Hox H; Oveland E; Woie K; Salvesen HB; Wiig H; Tenstad O
    Biochim Biophys Acta; 2013 Nov; 1834(11):2347-59. PubMed ID: 23707566
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tumor interstitial fluid - a treasure trove of cancer biomarkers.
    Gromov P; Gromova I; Olsen CJ; Timmermans-Wielenga V; Talman ML; Serizawa RR; Moreira JM
    Biochim Biophys Acta; 2013 Nov; 1834(11):2259-70. PubMed ID: 23416532
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interstitial fluid-a reflection of the tumor cell microenvironment and secretome.
    Haslene-Hox H; Tenstad O; Wiig H
    Biochim Biophys Acta; 2013 Nov; 1834(11):2336-46. PubMed ID: 23376185
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Quantitative Secretomic Analysis Identifies Extracellular Protein Factors That Modulate the Metastatic Phenotype of Non-Small Cell Lung Cancer.
    Hu R; Huffman KE; Chu M; Zhang Y; Minna JD; Yu Y
    J Proteome Res; 2016 Feb; 15(2):477-86. PubMed ID: 26736068
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Secretome proteomics for discovery of cancer biomarkers.
    Makridakis M; Vlahou A
    J Proteomics; 2010 Nov; 73(12):2291-305. PubMed ID: 20637910
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sulindac modulates secreted protein expression from LIM1215 colon carcinoma cells prior to apoptosis.
    Greening DW; Ji H; Kapp EA; Simpson RJ
    Biochim Biophys Acta; 2013 Nov; 1834(11):2293-307. PubMed ID: 23899461
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characterization of the Tumor Secretome from Tumor Interstitial Fluid (TIF).
    Gromov P; Gromova I
    Methods Mol Biol; 2016; 1459():231-47. PubMed ID: 27665563
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of head and neck squamous cell carcinoma biomarker candidates through proteomic analysis of cancer cell secretome.
    Marimuthu A; Chavan S; Sathe G; Sahasrabuddhe NA; Srikanth SM; Renuse S; Ahmad S; Radhakrishnan A; Barbhuiya MA; Kumar RV; Harsha HC; Sidransky D; Califano J; Pandey A; Chatterjee A
    Biochim Biophys Acta; 2013 Nov; 1834(11):2308-16. PubMed ID: 23665456
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Quantitative secretome analysis reveals the interactions between epithelia and tumor cells by in vitro modulating colon cancer microenvironment.
    Zeng X; Yang P; Chen B; Jin X; Liu Y; Zhao X; Liang S
    J Proteomics; 2013 Aug; 89():51-70. PubMed ID: 23748022
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Blood/plasma secretome and microvesicles.
    Inal JM; Kosgodage U; Azam S; Stratton D; Antwi-Baffour S; Lange S
    Biochim Biophys Acta; 2013 Nov; 1834(11):2317-25. PubMed ID: 23590876
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comprehensive fluorogenic derivatization-liquid chromatography/tandem mass spectrometry proteomic analysis of colorectal cancer cell to identify biomarker candidate.
    Koshiyama A; Ichibangase T; Imai K
    Biomed Chromatogr; 2013 Apr; 27(4):440-50. PubMed ID: 22991145
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Combination Strategy of Quantitative Proteomics Uncovers the Related Proteins of Colorectal Cancer in the Interstitial Fluid of Colonic Tissue from the AOM-DSS Mouse Model.
    Hou G; Wang Y; Lou X; Liu S
    Methods Mol Biol; 2018; 1788():185-192. PubMed ID: 29139078
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 35.